MX9600206A - Composiciones y metodos para estimular el crecimiento y la diferenciacion de los megacariocitos. - Google Patents
Composiciones y metodos para estimular el crecimiento y la diferenciacion de los megacariocitos.Info
- Publication number
- MX9600206A MX9600206A MX9600206A MX9600206A MX9600206A MX 9600206 A MX9600206 A MX 9600206A MX 9600206 A MX9600206 A MX 9600206A MX 9600206 A MX9600206 A MX 9600206A MX 9600206 A MX9600206 A MX 9600206A
- Authority
- MX
- Mexico
- Prior art keywords
- disclosed
- differentiation
- methods
- growth
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
Abstract
Se describen las proteínas novedosas, denominadas como factores de crecimiento y desarrollo de megacariocitos (MGDFs; también en general denominadas como ligandos de Mp1), que tienen actividad biologica de estimulacion del crecimiento de megacariocitos y aumento de la diferenciacion o maduracion de megacariocitos, que al final dan como resultado la produccion de plaquetas. Los derivados de MGDF que comprenden moléculas de MGDF unidas a polímeros solubles en agua, tales como polietilenglicol son también descritos, junto con los métodos para su produccion. También se describen los procesos para la obtencion de los MGDFs en forma homogénea a partir de fuentes naturales, y produciéndolos mediante técnicas recombinantes de ingeniería genética a partir de mamíferos, incluyendo humanos.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US221768 | 1980-12-31 | ||
US252628 | 1988-10-05 | ||
US22176894A | 1994-03-31 | 1994-03-31 | |
US25262894A | 1994-05-31 | 1994-05-31 | |
US08321488 | 1994-10-12 | ||
US08/321,488 US5795569A (en) | 1994-03-31 | 1994-10-12 | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
US34778094A | 1994-11-30 | 1994-11-30 | |
US347780 | 1994-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9600206A true MX9600206A (es) | 1998-11-30 |
MXPA96000206A MXPA96000206A (es) | 1999-01-15 |
Family
ID=
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6863589B2 (en) | 2003-04-03 | 2005-03-08 | Sara Lee Corporation | Tube brassiere and method of making |
US7662019B2 (en) | 2003-06-27 | 2010-02-16 | Hbi Branded Apparel Enterprises, Llc | Garment blanks, brassieres formed therefrom and method of forming the same |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6863589B2 (en) | 2003-04-03 | 2005-03-08 | Sara Lee Corporation | Tube brassiere and method of making |
US7662019B2 (en) | 2003-06-27 | 2010-02-16 | Hbi Branded Apparel Enterprises, Llc | Garment blanks, brassieres formed therefrom and method of forming the same |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV11783B (en) | Compositions and methods for stimulating megakaryocyte growth and differentiation | |
Munksgaard et al. | Collagen synthesis and secretion by rat incisor odontoblasts in organ culture | |
ATE147436T1 (de) | Menschliches cytokin, interleukin-9 | |
MX9602259A (es) | Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion. | |
ATE82495T1 (de) | Verfahren zur herstellung pharmazeutischer mischungen. | |
ATE215094T1 (de) | Komplement verwandte proteine und kohlenhydrate enthaltende zusammensetzungen und methoden zur herstellung und verwendung dieser zusammensetzungen | |
GB2344519B (en) | Sterile therapeutic compositions | |
WO1997023507A3 (en) | New form of amphiregulin, methods for producing and using the same and compositions comprising the same | |
ATE25708T1 (de) | Biologisch aktive konjugate, ihre herstellung und ihre anwendung. | |
AU4655899A (en) | A novel human thrombopoietin mutein | |
DE69032471T2 (de) | Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung | |
ES8705466A1 (es) | Un metodo para la preparacion del factor nkbs regulador del cancer humano. | |
WO2002064754B1 (de) | Medium zur züchtung von tumorzellen | |
DE68918269D1 (de) | Pflanzenvirusbekämpfungsmittel und verfahren zur herstellung. | |
MX9705572A (es) | Complejos estables para el suministro de farmacos que contienen lipidos y metodos para su produccion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |